Literature DB >> 10781849

Immune responses induced by recombinant BCG strains according to level of production of a foreign antigen: malE.

H Himmelrich1, R Lo-Man, N Winter, P Guermonprez, C Sedlik, M Rojas, D Monnaie, M Gheorghiu, M Lagranderie, M Hofnung, B Gicquel, J M Clément, C Leclerc.   

Abstract

A variety of viral, bacterial and parasitic antigens have been expressed in BCG and the capacity of these recombinant bacteria to induce immune responses has been well documented. However, little is known about the parameters influencing the induction of immune responses by recombinant BCG (rBCG), such as level of production and localization of the recombinant antigen. In the present study, we have constructed several rBCG strains expressing the malE gene from Escherichia coli which is either secreted or targeted to the cytoplasm or plasma membrane. Expression of malE was quantified by ELISA and localization was analyzed by flow cytometry. Even when using the same promoter, levels of cytoplasmic or membrane MalE production were far less than those from secreting strains using either mycobacterial or E. coli secretion signals. Stronger and more rapid immune responses were induced by rBCG strains with the highest levels of secreted MalE compared to cytoplasmic or membrane constructs, including both good humoral and proliferative responses in BALB/c, C57BL6 and even C3H mice, previously shown to be poor MalE responders. These results suggest that the levels of foreign antigen production play an important role in the induction of immune responses by rBCG strains.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781849     DOI: 10.1016/s0264-410x(00)00070-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in mice.

Authors:  Michela Sali; Gabriele Di Sante; Alessandro Cascioferro; Antonella Zumbo; Chiara Nicolò; Valentina Donà; Stefano Rocca; Annabella Procoli; Matteo Morandi; Francesco Ria; Giorgio Palù; Giovanni Fadda; Riccardo Manganelli; Giovanni Delogu
Journal:  Infect Immun       Date:  2010-10-04       Impact factor: 3.441

2.  Generation of mucosal anti-human immunodeficiency virus type 1 T-cell responses by recombinant Mycobacterium smegmatis.

Authors:  Jae-Sung Yu; James W Peacock; Stacie Vanleeuwen; Tsungda Hsu; William R Jacobs; Mark J Cayabyab; Norman L Letvin; Richard Frothingham; Herman F Staats; Hua-Xin Liao; Barton F Haynes
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

3.  Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin.

Authors:  E N Miyaji; R P Mazzantini; W O Dias; A L Nascimento; R Marcovistz; D S Matos; I Raw; N Winter; B Gicquel; R Rappuoli; L C Leite
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 4.  Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.

Authors:  Rosamund Chapman; Gerald Chege; Enid Shephard; Helen Stutz; Anna-Lise Williamson
Journal:  Curr HIV Res       Date:  2010-06       Impact factor: 1.581

5.  Closely related mycobacterial strains demonstrate contrasting levels of efficacy as antitumor vaccines and are processed for major histocompatibility complex class I presentation by multiple routes in dendritic cells.

Authors:  Eleanor J Cheadle; Dearbhaile O'Donnell; Peter J Selby; Andrew M Jackson
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

6.  Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion.

Authors:  Natalie Taylor; Faith Bahunde; Afton Thompson; Jae-Sung Yu; William R Jacobs; Norm L Letvin; Barton F Haynes; Sunhee Lee
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

7.  Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge.

Authors:  Paula B Varaldo; Luciana C C Leite; Waldely O Dias; Eliane N Miyaji; Fabio I G Torres; Vera C Gebara; Geraldo R G Armôa; Adriano S Campos; Denise C S Matos; Nathalie Winter; Brigitte Gicquel; Mônica M Vilar; Johnjoe McFadden; Marilia S Almeida; Miriam Tendler; Douglas McIntosh
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

8.  Stable expression of Mycobacterium bovis antigen 85B in auxotrophic M. bovis bacillus Calmette-Guérin.

Authors:  Caroline Rizzi; Ana Carolina Peiter; Thaís Larré Oliveira; Amilton Clair Pinto Seixas; Karen Silva Leal; Daiane Drawanz Hartwig; Fabiana Kommling Seixas; Sibele Borsuk; Odir Antônio Dellagostin
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-02       Impact factor: 2.743

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.